IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q2 2021 Holdings

Filed 2021-08-16 | 30 holdings | $38.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Collegium Pharmaceutical Inc(COLL)COM19459J104$20.4M861,41053.0%
Biogen Inc(BIIB)COM09062X103$11.3M32,50029.3%
Cytomx Therapeutics Inc(CTMX)COM23284F105$6.3M1,000,00016.5%
Macrogenics Inc(MGNX)COM556099109$37.0K1,378,4950.1%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$36.2K817,0400.1%
Arena Pharmaceuticals Inc(ARNAEUR)COM NEW040047607$34.5K505,6700.1%
United Therapeutics Corp del(UTHR)COM91307C102$31.6K176,4060.1%
Insulet Corp(PODD)COM45784P101$28.7K104,6000.1%
Exelixis Inc(EXEL)COM30161Q104$25.4K1,394,1070.1%
Kadmon Hldgs Inc(KDMN)COM48283N106$18.7K4,830,0000.0%
Intellia Therapeutics Inc(NTLA)CallCOM45826J105$16.2K100,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$16.2K100,0000.0%
Travere Therapeutics Inc(TVTX)COM89422G107$15.8K1,084,3000.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$15.4K1,600,0000.0%
Sage Therapeutics Inc(SG7)COM78667J108$14.2K250,0000.0%
Dyne Therapeutics Inc(DYN)COM26818M108$14.2K672,5590.0%
Repare Therapeutics Inc(RPTX)COM760273102$13.6K436,0890.0%
Fibrogen Inc(FGENEUR)CallCOM31572Q808$13.3K500,0000.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$13.0K919,8870.0%
Intersect ENT IncCOM46071F103$12.0K700,0000.0%
Puma Biotechnology Inc(PBYI)COM74587V107$11.9K1,300,0000.0%
Magenta Therapeutics IncCOM55910K108$10.9K1,111,1110.0%
Kura Oncology Inc(KURA)COM50127T109$10.4K500,0000.0%
Anaptysbio Inc(ANAB)COM032724106$10.4K400,0510.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$9.2K329,0860.0%
Tricida Inc(1T7)COM89610F101$8.5K1,974,0000.0%
Inflarx NV(IFRX)COMN44821101$6.5K2,200,0000.0%
Rigel Pharmaceuticals Inc(RIGLUSD)COM NEW766559603$6.5K1,500,0000.0%
Aeglea Biotherapeutics Inc(AGLEUSD)COM00773J103$6.3K900,0000.0%
Verve Therapeutics IncCOM92539P101$2.1K35,0000.0%